Science 7 March 1986: Vol. 231. no. 4742, pp. 1145 - 1147 DOI: 10.1126/science.2935937

Prev | Table of Contents | Next

Articles

A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions..

P. M. McKie, A. Cataliotti, B. K. Huntley, F. L. Martin, T. M. Olson, and J. C. Burnett Jr (2009)
J. Am. Coll. Cardiol. 54, 1024-1032
 |  Abstract »  |  Full Text »  |  PDF »

Endurance Training in the Spontaneously Hypertensive Rat: Conversion of Pathological into Physiological Cardiac Hypertrophy.

C. D. Garciarena, O. A. Pinilla, M. B. Nolly, R. P. Laguens, E. M. Escudero, H. E. Cingolani, and I. L. Ennis (2009)
Hypertension 53, 708-714
 |  Abstract »  |  Full Text »  |  PDF »

Role of Natriuretic Peptides in cGMP Production in Fetal Cardiac Bypass..

E. A. Heeb, R. S. Baker, C. Lam, M. Basu, W. Lubbers, J. Y. Duffy, and P. Eghtesady (2009)
Ann. Thorac. Surg. 87, 841-847
 |  Abstract »  |  Full Text »  |  PDF »

Endothelin-Stimulated Human B-Type Natriuretic Peptide Gene Expression Is Mediated by Yin Yang 1 in Association With Histone Deacetylase 2.

D. J. Glenn, F. Wang, S. Chen, M. Nishimoto, and D. G. Gardner (2009)
Hypertension 53, 549-555
 |  Abstract »  |  Full Text »  |  PDF »

Alternative Splicing of the Guanylyl Cyclase-A Receptor Modulates Atrial Natriuretic Peptide Signaling.

M. Hartmann, B. V. Skryabin, T. Muller, A. Gazinski, J. Schroter, B. Gassner, V. O. Nikolaev, M. Bunemann, and M. Kuhn (2008)
J. Biol. Chem. 283, 28313-28320
 |  Abstract »  |  Full Text »  |  PDF »

Atrial Natriuretic Peptide Frameshift Mutation in Familial Atrial Fibrillation.

D. M. Hodgson-Zingman, M. L. Karst, L. V. Zingman, D. M. Heublein, D. Darbar, K. J. Herron, J. D. Ballew, M. de Andrade, J. C. Burnett Jr., and T. M. Olson (2008)
N. Engl. J. Med. 359, 158-165
 |  Abstract »  |  Full Text »  |  PDF »

Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure.

F. L. Martin, T. Supaporn, H. H. Chen, S. M. Sandberg, Y. Matsuda, M. Jougasaki, and J. C. Burnett Jr. (2007)
Am J Physiol Regulatory Integrative Comp Physiol 293, R1580-R1585
 |  Abstract »  |  Full Text »  |  PDF »

The Repressor Element 1-Silencing Transcription Factor Regulates Heart-Specific Gene Expression Using Multiple Chromatin-Modifying Complexes.

A. J. Bingham, L. Ooi, L. Kozera, E. White, and I. C. Wood (2007)
Mol. Cell. Biol. 27, 4082-4092
 |  Abstract »  |  Full Text »  |  PDF »

Alternate Circulating Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide Forms in the General Population.

C. S.P. Lam, J. C. Burnett Jr, L. Costello-Boerrigter, R. J. Rodeheffer, and M. M. Redfield (2007)
J. Am. Coll. Cardiol. 49, 1193-1202
 |  Abstract »  |  Full Text »  |  PDF »

Acute Phosphodiesterase 5 Inhibition Mimics Hemodynamic Effects of B-Type Natriuretic Peptide and Potentiates B-Type Natriuretic Peptide Effects in Failing But Not Normal Canine Heart.

P. R. Forfia, M. Lee, R. S. Tunin, M. Mahmud, H. C. Champion, and D. A. Kass (2007)
J. Am. Coll. Cardiol. 49, 1079-1088
 |  Abstract »  |  Full Text »  |  PDF »

Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy.

P. Belluardo, A. Cataliotti, L. Bonaiuto, E. Giuffre, E. Maugeri, P. Noto, G. Orlando, G. Raspa, B. Piazza, L. Babuin, et al. (2006)
Am J Physiol Heart Circ Physiol 291, H1529-H1535
 |  Abstract »  |  Full Text »  |  PDF »

Novel Snake Venom Ligand Dendroaspis Natriuretic Peptide Is Selective for Natriuretic Peptide Receptor-A in Human Heart: Downregulation of Natriuretic Peptide Receptor-A in Heart Failure.

G. Singh, R. E. Kuc, J. J. Maguire, M. Fidock, and A. P. Davenport (2006)
Circ. Res. 99, 183-190
 |  Abstract »  |  Full Text »  |  PDF »

Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.

M. Rienstra, I. C. Van Gelder, M. P. Van den Berg, F. Boomsma, and D. J. Van Veldhuisen (2006)
Europace 8, 482-487
 |  Abstract »  |  Full Text »  |  PDF »

Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat.

Y.-M. Cha, P. P. Dzeja, M. M. Redfield, W. K. Shen, and A. Terzic (2006)
Am J Physiol Heart Circ Physiol 290, H1686-H1692
 |  Abstract »  |  Full Text »  |  PDF »

Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions.

L. R. Potter, S. Abbey-Hosch, and D. M. Dickey (2006)
Endocr. Rev. 27, 47-72
 |  Abstract »  |  Full Text »  |  PDF »

The role of natriuretic peptides in cardioprotection.

T. Nishikimi, N. Maeda, and H. Matsuoka (2006)
Cardiovasc Res 69, 318-328
 |  Abstract »  |  Full Text »  |  PDF »

A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.

M. Murakami, M. Nakagawa, E. N. Olson, and O. Nakagawa (2005)
PNAS 102, 18034-18039
 |  Abstract »  |  Full Text »  |  PDF »

Coronary artery disease, heart failure, and cardiac natriuretic peptides in the middle.

J. P. Goetze (2005)
Eur. Heart J. 26, 2603-2604
 |  Full Text »  |  PDF »

Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats.

C. A. Emter, S. A. McCune, G. C. Sparagna, M. J. Radin, and R. L. Moore (2005)
Am J Physiol Heart Circ Physiol 289, H2030-H2038
 |  Abstract »  |  Full Text »  |  PDF »

Oral Human Brain Natriuretic Peptide Activates Cyclic Guanosine 3',5'-Monophosphate and Decreases Mean Arterial Pressure.

A. Cataliotti, J. A. Schirger, F. L. Martin, H. H. Chen, P. M. McKie, G. Boerrigter, L. C. Costello-Boerrigter, G. Harty, D. M. Heublein, S. M. Sandberg, et al. (2005)
Circulation 112, 836-840
 |  Abstract »  |  Full Text »  |  PDF »

B-Type Natriuretic Peptide as a Biomarker Beyond Heart Failure: Speculations and Opportunities.

P. M. McKie and J. C. Burnett Jr (2005)
Mayo Clin. Proc. 80, 1029-1036
 |  Abstract »  |  PDF »

Dual ECE/NEP Inhibition on Cardiac and Neurohumoral Function During the Transition From Hypertrophy to Heart Failure in Rats.

N. Emoto, S. B. Raharjo, D. Isaka, S. Masuda, S. Adiarto, A. Y. Jeng, and M. Yokoyama (2005)
Hypertension 45, 1145-1152
 |  Abstract »  |  Full Text »  |  PDF »

B-Type Natriuretic Peptide in Organic Mitral Regurgitation: Determinants and Impact on Outcome.

D. Detaint, D. Messika-Zeitoun, J.-F. Avierinos, C. Scott, H. Chen, J. C. Burnett Jr, and M. Enriquez-Sarano (2005)
Circulation 111, 2391-2397
 |  Abstract »  |  Full Text »  |  PDF »

Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium.

K. L. Tran, X. Lu, M. Lei, Q. Feng, and Q. Wu (2004)
Am J Physiol Heart Circ Physiol 287, H1625-H1631
 |  Abstract »  |  Full Text »  |  PDF »

Plasma Level of B-Type Natriuretic Peptide as a Prognostic Marker After Acute Myocardial Infarction: A Long-Term Follow-Up Analysis.

S. Suzuki, M. Yoshimura, M. Nakayama, Y. Mizuno, E. Harada, T. Ito, S. Nakamura, K. Abe, M. Yamamuro, T. Sakamoto, et al. (2004)
Circulation 110, 1387-1391
 |  Abstract »  |  Full Text »  |  PDF »

Biochemistry of Pro-B-Type Natriuretic Peptide-Derived Peptides: The Endocrine Heart Revisited.

J. P. Goetze (2004)
Clin. Chem. 50, 1503-1510
 |  Abstract »  |  Full Text »  |  PDF »

Measuring plasma B-type natriuretic peptide in heart failure: Good to go in 2004?.

R. J. Rodeheffer (2004)
J. Am. Coll. Cardiol. 44, 740-749
 |  Abstract »  |  Full Text »  |  PDF »

Brain Natriuretic Peptide Enhances Renal Actions of Furosemide and Suppresses Furosemide-Induced Aldosterone Activation in Experimental Heart Failure.

A. Cataliotti, G. Boerrigter, L. C. Costello-Boerrigter, J. A. Schirger, T. Tsuruda, D. M. Heublein, H. H. Chen, L. S. Malatino, and J. C. Burnett Jr (2004)
Circulation 109, 1680-1685
 |  Abstract »  |  Full Text »  |  PDF »

NT-proBNP in heart failure: therapy decisions and monitoring.

M. Richards and R. W. Troughton (2004)
Eur J Heart Fail 6, 351-354
 |  Abstract »  |  Full Text »  |  PDF »

B-Type Natriuretic Peptide: A Diagnostic, Prognostic, and Therapeutic Tool in Heart Failure.

A. Prahash and T. Lynch (2004)
Am. J. Crit. Care. 13, 46-53
 |  Abstract »  |  Full Text »  |  PDF »

Amino-Terminal Pro-C-Type Natriuretic Peptide in Heart Failure.

S. P. Wright, T. C.R. Prickett, R. N. Doughty, C. Frampton, G. D. Gamble, T. G. Yandle, N. Sharpe, and M. Richards (2004)
Hypertension 43, 94-100
 |  Abstract »  |  Full Text »  |  PDF »

Tbx5 specifies the left/right ventricles and ventricular septum position during cardiogenesis.

J. K. Takeuchi, M. Ohgi, K. Koshiba-Takeuchi, H. Shiratori, I. Sakaki, K. Ogura, Y. Saijoh, and T. Ogura (2003)
Development 130, 5953-5964
 |  Abstract »  |  Full Text »  |  PDF »

Corin-Mediated Processing of Pro-Atrial Natriuretic Peptide in Human Small Cell Lung Cancer Cells.

F. Wu and Q. Wu (2003)
Cancer Res. 63, 8318-8322
 |  Abstract »  |  Full Text »  |  PDF »

Structure, Regulation, and Function of Mammalian Membrane Guanylyl Cyclase Receptors, With a Focus on Guanylyl Cyclase-A.

M. Kuhn (2003)
Circ. Res. 93, 700-709
 |  Abstract »  |  Full Text »  |  PDF »

Atrial Natriuretic Peptide Induces Natriuretic Peptide Receptor-cGMP-dependent Protein Kinase Interaction.

N. Airhart, Y.-F. Yang, C. T. Roberts Jr., and M. Silberbach (2003)
J. Biol. Chem. 278, 38693-38698
 |  Abstract »  |  Full Text »  |  PDF »

The rise and fall of myotrophin in heart failure.

J. J. V. McMurray and C. Hillier (2003)
J. Am. Coll. Cardiol. 42, 726-727
 |  Full Text »  |  PDF »

Cardiac Hormones as Diagnostic Tools in Heart Failure.

H. Ruskoaho (2003)
Endocr. Rev. 24, 341-356
 |  Abstract »  |  Full Text »  |  PDF »

Myocardial Production of C-Type Natriuretic Peptide in Chronic Heart Failure.

P. R. Kalra, J. R. Clague, A. P. Bolger, S. D. Anker, P. A. Poole-Wilson, A. D. Struthers, and A. J. Coats (2003)
Circulation 107, 571-573
 |  Abstract »  |  Full Text »  |  PDF »

Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions.

T. Hakala, A. Hedman, A. Turpeinen, R. Kettunen, O. Vuolteenaho, and M. Hippelainen (2002)
Eur. J. Cardiothorac. Surg. 22, 939-943
 |  Abstract »  |  Full Text »  |  PDF »

Stem cell differentiation requires a paracrine pathway in the heart.

A. BEHFAR, L. V. ZINGMAN, D. M. HODGSON, J.-M. RAUZIER, G. C. KANE, A. TERZIC, and M. PUCEAT (2002)
FASEB J 16, 1558-1566
 |  Abstract »  |  Full Text »  |  PDF »

Angiotensin-Converting Enzyme Genotype Modulates Pulmonary Function and Exercise Capacity in Treated Patients With Congestive Stable Heart Failure.

M.R. Abraham, L. J. Olson, M. J. Joyner, S. T. Turner, K. C. Beck, and B. D. Johnson (2002)
Circulation 106, 1794-1799
 |  Abstract »  |  Full Text »  |  PDF »

Nesiritide: A New Drug for the Treatment of Decompensated Heart Failure.

U. Elkayam, M. W. Akhter, P. Tummala, S. Khan, and H. Singh (2002)
Journal of Cardiovascular Pharmacology and Therapeutics 7, 181-194
 |  Abstract »  |  PDF »

Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure.

W. Johnson, T. Omland, C. Hall, C. Lucas, O. L. Myking, C. Collins, M. Pfeffer, J.-L. Rouleau, and L. W. Stevenson (2002)
J. Am. Coll. Cardiol. 39, 1623-1629
 |  Abstract »  |  Full Text »  |  PDF »

Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac Myocytes.

F. Wu, W. Yan, J. Pan, J. Morser, and Q. Wu (2002)
J. Biol. Chem. 277, 16900-16905
 |  Abstract »  |  Full Text »  |  PDF »

Actions of a novel synthetic natriuretic peptide on hemodynamics and ventricular function in the dog.

J. G. Lainchbury, O. Lisy, J. C. Burnett Jr., D. M. Meyer, and M. M. Redfield (2002)
Am J Physiol Regulatory Integrative Comp Physiol 282, R993-R998
 |  Abstract »  |  Full Text »  |  PDF »

Induction and maintenance of an experimental model of severe cardiomyopathy with a novel protocol of rapid ventricular pacing.

M. Takagaki, P. M. McCarthy, T. Tabata, R. Dessoffy, L. A. Cardon, J. Connor, Y. Ochiai, J. D. Thomas, G. S. Francis, J. B. Young, et al. (2002)
J. Thorac. Cardiovasc. Surg. 123, 544-549
 |  Abstract »  |  Full Text »  |  PDF »

Assessment of Cardiac Function in Adolescents With Duchenne Muscular Dystrophy: Importance of Neurohormones.

C. Ramaciotti, W. A. Scott, M. S. Lemler, C. Haverland, and S. T. Iannaccone (2002)
J Child Neurol 17, 191-194
 |  Abstract »  |  PDF »

Differential Actions of Vasopeptidase Inhibition Versus Angiotensin-Converting Enzyme Inhibition on Diuretic Therapy in Experimental Congestive Heart Failure.

A. Cataliotti, G. Boerrigter, H. H. Chen, M. Jougasaki, L. C. Costello, T. Tsuruda, S.-C. Lee, L. S. Malatino, and J. C. Burnett Jr (2002)
Circulation 105, 639-644
 |  Abstract »  |  Full Text »  |  PDF »

Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular function.

W. L. Miller, K. R. Bailey, S. A. Weston, J. C. Burnett Jr., and R. J. Rodeheffer (2002)
Eur J Heart Fail 4, 63-72
 |  Abstract »  |  Full Text »  |  PDF »

Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems.

R. Sodian, M. Loebe, C. Schmitt, E. V. Potapov, H. Siniawski, J. Muller, H. Hausmann, H. R. Zurbruegg, Y. Weng, and R. Hetzer (2001)
J. Am. Coll. Cardiol. 38, 1942-1949
 |  Abstract »  |  Full Text »  |  PDF »

Vasopeptidase Inhibitors: A New Therapeutic Concept in Cardiovascular Disease?.

R. Corti, J. C. Burnett Jr, J. L. Rouleau, F. Ruschitzka, and T. F. Luscher (2001)
Circulation 104, 1856-1862
 |  Abstract »  |  Full Text »  |  PDF »

Differential Secretion of Atrial and Brain Natriuretic Peptide in Critically Ill Patients.

E. Berendes, H. Van Aken, C. Raufhake, C. Schmidt, G. Assmann, and M. Walter (2001)
Anesth. Analg. 93, 676-682
 |  Abstract »  |  Full Text »  |  PDF »

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

F. Boomsma and A. H. van den Meiracker (2001)
Cardiovasc Res 51, 442-449
 |  Full Text »  |  PDF »

Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.

P. R Kalra, S. D Anker, and A. J.S Coats (2001)
Cardiovasc Res 51, 495-509
 |  Full Text »  |  PDF »

Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula.

Z. A. Abassi, S. Brodsky, T. Karram, I. Dobkin, J. Winaver, and A. Hoffman (2001)
Cardiovasc Res 51, 567-576
 |  Abstract »  |  Full Text »  |  PDF »

Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload.

Y. Hirata, A. Matsumoto, T. Aoyagi, K. Yamaoki, I. Komuro, T. Suzuki, T. Ashida, T. Sugiyama, Y. Hada, I. Kuwajima, et al. (2001)
Cardiovasc Res 51, 585-591
 |  Abstract »  |  Full Text »  |  PDF »

Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.

T. Maki, Y. Nasa, F. Yamaguchi, H. Yoshida, M. Mori, T. Takada, E. Horikawa, K. Okano, and S. Takeo (2001)
Cardiovasc Res 51, 608-617
 |  Abstract »  |  Full Text »  |  PDF »

Vasopeptidase inhibitors--concepts and evidence.

F. Ruschitzka, R. Corti, T. Quaschning, M. Hermann, and T. F. Luscher (2001)
Nephrol. Dial. Transplant. 16, 1532-1535
 |  Full Text »  |  PDF »

Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy.

C Briguori, S Betocchi, F Manganelli, B Gigante, M.A Losi, Q Ciampi, R Gottilla, A Violante, C.G Tocchetti, M Volpe, et al. (2001)
Eur. Heart J. 22, 1328-1336
 |  Abstract »  |  PDF »

Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones.

M. G. Andreassi, S. Del Ry, C. Palmieri, A. Clerico, A. Biagini, and D. Giannessi (2001)
Eur J Heart Fail 3, 407-414
 |  Abstract »  |  Full Text »  |  PDF »

Endogenous Natriuretic Peptides Participate in Renal and Humoral Actions of Acute Vasopeptidase Inhibition in Experimental Mild Heart Failure.

H. H. Chen, J. G. Lainchbury, Y. Matsuda, G. J. Harty, and J. C. Burnett Jr (2001)
Hypertension 38, 187-191
 |  Abstract »  |  Full Text »  |  PDF »

Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.

C. Y. T. Hart, E. L. Hahn, D. M. Meyer, J. C. Burnett Jr., and M. M. Redfield (2001)
Am J Physiol Heart Circ Physiol 281, H146-H154
 |  Abstract »  |  Full Text »  |  PDF »

The role of C-type natriuretic peptide in cardiovascular medicine.

P.R Kalra, S.D Anker, A.D Struthers, and A.J.S Coats (2001)
Eur. Heart J. 22, 997-1007
 |  PDF »

Therapeutic Actions of a New Synthetic Vasoactive and Natriuretic Peptide, Dendroaspis Natriuretic Peptide, in Experimental Severe Congestive Heart Failure.

O. Lisy, J. G. Lainchbury, H. Leskinen, and J. C. Burnett Jr (2001)
Hypertension 37, 1089-1094
 |  Abstract »  |  Full Text »  |  PDF »

Cardiac peptides and plasma renin activity in acute dilated cardiomyopathy.

C. G. Missouris, C. Varma, D. Ward, and G. A. MacGregor (2001)
Eur J Heart Fail 3, 109-111
 |  Full Text »  |  PDF »

Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition.

L. V. d'Uscio, T. Quaschning, J. C. Burnett Jr, and T. F. Luscher (2001)
Hypertension 37, 28-33
 |  Abstract »  |  Full Text »  |  PDF »

Relationship between left ventricular wall stress and ANP gene expression during the evolution of rapid ventricular pacing-induced heart failure in the dog.

A. Luchner, D. D. Borgeson, J. A. Grantham, E. Friedrich, G. A.J. Riegger, J. C. Burnett Jr, and M. M. Redfield (2000)
Eur J Heart Fail 2, 379-386
 |  Abstract »  |  Full Text »  |  PDF »

Protein kinase G reverses all isoproterenol induced changes of cardiac single L-type calcium channel gating.

G. Klein, H. Drexler, and F. Schroder (2000)
Cardiovasc Res 48, 367-374
 |  Abstract »  |  Full Text »  |  PDF »

Subcutaneous administration of brain natriuretic peptide in experimental heart failure.

H. H. Chen, J. A. Grantham, J. A. Schirger, M. Jougasaki, M. M. Redfield, and J. C. Burnett Jr. (2000)
J. Am. Coll. Cardiol. 36, 1706-1712
 |  Abstract »  |  Full Text »  |  PDF »

Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction.

K. Maeda, T. Tsutamoto, A. Wada, N. Mabuchi, M. Hayashi, T. Hisanaga, T. Kamijo, and M. Kinoshita (2000)
J Appl Physiol 89, 458-464
 |  Abstract »  |  Full Text »  |  PDF »

Mechanical Unloading Versus Neurohumoral Stimulation on Myocardial Structure and Endocrine Function In Vivo.

O. Lisy, M. M. Redfield, S. Jovanovic, M. Jougasaki, A. Jovanovic, H. Leskinen, A. Terzic, and J. C. Burnett Jr (2000)
Circulation 102, 338-343
 |  Abstract »  |  Full Text »  |  PDF »

ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models.

L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN (2000)
Physiol Genomics 3, 45-58
 |  Abstract »  |  Full Text »  |  PDF »

Atrial Natriuretic Factor Binding to Its Receptor Is Dependent on Chloride Concentration : A Possible Feedback-Control Mechanism in Renal Salt Regulation.

K. S. Misono (2000)
Circ. Res. 86, 1135-1139
 |  Abstract »  |  Full Text »  |  PDF »

Natriuretic peptide levels in atrial fibrillation: A prospective hormonal and Doppler-echocardiographic study.

A. Rossi, M. Enriquez-Sarano, J. C. Burnett Jr., A. Lerman, M. D. Abel, and J. B. Seward (2000)
J. Am. Coll. Cardiol. 35, 1256-1262
 |  Abstract »  |  Full Text »  |  PDF »

Neurohormonal activation late after cavopulmonary connection.

V E Hjortdal, E V Stenbøg, H B Ravn, K Emmertsen, K T Jensen, E B Pedersen, K H Olsen, O K Hansen, and K E Sørensen (2000)
Heart 83, 439-443
 |  Abstract »  |  Full Text »

Is the secretion of atrial natriuretic peptide in man under neural control?.

G McDowell, M Cave, A Bainbridge, M Danton, C Shaw, K.D Buchanan, J Wallwork, S Large, and D.P Nicholls (2000)
Eur. Heart J. 21, 498-503
 |  Abstract »  |  PDF »

The modulating actions of sulfonylurea on atrial natriuretic peptide release in experimental acute heart failure.

H. H. Chen, K. Y. Oh, A. Terzic, and J. C. Burnett Jr. (2000)
Eur J Heart Fail 2, 33-40
 |  Abstract »  |  Full Text »  |  PDF »

Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs.

J. G. Lainchbury, J. C. Burnett Jr., D. Meyer, and M. M. Redfield (2000)
Am J Physiol Heart Circ Physiol 278, H33-H40
 |  Abstract »  |  Full Text »  |  PDF »

Renal Response to Acute Neutral Endopeptidase Inhibition in Mild and Severe Experimental Heart Failure.

H. H. Chen, J. A. Schirger, W. L. Chau, M. Jougasaki, O. Lisy, M. M. Redfield, P. T. Barclay, and J. C. Burnett Jr (1999)
Circulation 100, 2443-2448
 |  Abstract »  |  Full Text »  |  PDF »

Modulation of endocardial natriuretic peptide receptors in right ventricular hypertrophy.

S. Z. Kim, K. W. Cho, and S. H. Kim (1999)
Am J Physiol Heart Circ Physiol 277, H2280-H2289
 |  Abstract »  |  Full Text »  |  PDF »

Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat.

F. Brunner (1999)
Cardiovasc Res 44, 197-206
 |  Abstract »  |  Full Text »  |  PDF »

Elevated Plasma Atrial Natriuretic Peptide Levels After Occlusion of the Thoracic Aorta.

H. Berkenstadt, T. Rosenthal, E. Peleg, E. Segal, A. Hackshaw, G. Ben-Ari, and A. Perel (1999)
Chest 115, 130-134
 |  Abstract »  |  Full Text »  |  PDF »

ANP and Bradycardic Reflexes in Hypertensive Rats : Influence of Cardiac Hypertrophy.

C. J. Thomas, G. A. Head, and R. L. Woods (1998)
Hypertension 32, 548-555
 |  Abstract »  |  Full Text »  |  PDF »

Natriuretic Peptides.

E. R. Levin, D. G. Gardner, and W. K. Samson (1998)
N. Engl. J. Med. 339, 321-328
 |  Full Text »  |  PDF »

Chronic Oral Endothelin Type A Receptor Antagonism in Experimental Heart Failure.

D. D. Borgeson, J. A. Grantham, E. E. Williamson, A. Luchner, M. M. Redfield, T. J. Opgenorth, and J. C. Burnett Jr (1998)
Hypertension 31, 766-770
 |  Abstract »  |  Full Text »  |  PDF »

Low-Dose C-Type Natriuretic Peptide Does Not Affect Cardiac and Renal Function in Humans.

G. Barletta, C. Lazzeri, S. Vecchiarino, R. Del Bene, G. Messeri, A. Dello Sbarba, M. Mannelli, and G. La Villa (1998)
Hypertension 31, 802-808
 |  Abstract »  |  Full Text »  |  PDF »

Na+ influx and Na+-K+ pump activation during short-term exposure of cardiac myocytes to aldosterone.

A. S. Mihailidou, K. A. Buhagiar, and H. H. Rasmussen (1998)
Am J Physiol Cell Physiol 274, C175-C181
 |  Abstract »  |  Full Text »  |  PDF »

Neutral Endopeptidase Regulates C-Type Natriuretic Peptide Metabolism But Does Not Potentiate Its Bioactivity In Vivo.

R. R. Brandt, M. T. Mattingly, A. L. Clavell, P. L. Barclay, and J. C. Burnett Jr (1997)
Hypertension 30, 184-190
 |  Abstract »  |  Full Text »

Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy.

K. Yamamoto, J. C. Burnett Jr, M. Jougasaki, R. A. Nishimura, K. R. Bailey, Y. Saito, K. Nakao, and M. M. Redfield (1996)
Hypertension 28, 988-994
 |  Abstract »  |  Full Text »

Evidence for Functional Relevance of an Enhanced Expression of the Na+-Ca2+ Exchanger in Failing Human Myocardium.

M. Flesch, R. H.G. Schwinger, F. Schiffer, K. Frank, M. Sudkamp, F. Kuhn-Regnier, G. Arnold, and M. Bohm (1996)
Circulation 94, 992-1002
 |  Abstract »  |  Full Text »

Angiotensin II in the Evolution of Experimental Heart Failure.

A. Luchner, T. L. Stevens, D. D. Borgeson, M. M. Redfield, J. E. Bailey, S. M. Sandberg, D. M. Heublein, and J. C. Burnett (1996)
Hypertension 28, 472-477
 |  Abstract »  |  Full Text »

Differing Metabolism and Bioactivity of Atrial and Brain Natriuretic Peptides in Essential Hypertension.

G. B. Pidgeon, A. M. Richards, M. G. Nicholls, E. A. Espiner, T. G. Yandle, and C. Frampton (1996)
Hypertension 27, 906-913
 |  Abstract »  |  Full Text »

Natriuretic Peptide Receptors in Human Artery and Vein and Rabbit Vein Graft.

T. Ikeda, H. Itoh, Y. Komatsu, M. Hanyu, T. Yoshimasa, K. Matsuda, K. Nakao, and T. Ban (1996)
Hypertension 27, 833-837
 |  Abstract »  |  Full Text »

ATRIAL NATIURETIC PEPTIDE RELEASE AT REST AND WITH EXERCISE AFTER CARDIAC TRANSPLANTATION WITH BICAVAL ANASTOMOSES.

A. W. Jahnke, R. Leyh, A. Bernhard, and H. H. Sievers (1995)
J. Thorac. Cardiovasc. Surg. 110, 1600-1605
 |  Abstract »  |  Full Text »

Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure.

F. Pieruzzi, Z. A. Abassi, and H. R. Keiser (1995)
Circulation 92, 3105-3112
 |  Abstract »  |  Full Text »

Inhibition by Cardiac Natriuretic Peptides of Rat Vascular Endothelial Cell Migration.

M. Ikeda, M. Kohno, and T. Takeda (1995)
Hypertension 26, 401-405
 |  Abstract »  |  Full Text »

Elevation of Circulating and Ventricular Adrenomedullin in Human Congestive Heart Failure.

M. Jougasaki, C.-M. Wei, L. J. McKinley, and J. C. Burnett Jr (1995)
Circulation 92, 286-289
 |  Abstract »  |  Full Text »

Influence of Atrial Natriuretic Factor on Spontaneous Baroreflex Sensitivity for Heart Rate in Humans.

G. C. Butler, B. L. Senn, and J. S. Floras (1995)
Hypertension 25, 1167-1171
 |  Abstract »  |  Full Text »

To Advertise   |   Find Products